Get the Stockscreener App
11.96
11.57%
1.24
After Hours:
11.92
-0.04
-0.33%
Scilex Holding Company stock is traded at $11.96, with a volume of 240.85K.
It is up +11.57% in the last 24 hours and up +122.30% over the past month.
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$10.72
Open:
$10.88
24h Volume:
240.85K
Relative Volume:
1.59
Market Cap:
$83.14M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-9.2713
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
+34.99%
1M Performance:
+122.30%
6M Performance:
-22.41%
1Y Performance:
-79.90%
1-Day Range:
$10.14
$11.98
1-Week Range:
$7.975
$12.41
52-Week Range:
$3.60
$59.85
Scilex Holding Company Stock (SCLX) Company Profile
Name
Scilex Holding Company
Sector
Industry
Phone
(650) 516-4310
Address
960 SAN ANTONIO ROAD, PALO ALTO
Compare SCLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCLX
Scilex Holding Company
|
11.96 | 58.89M | 46.74M | -114.33M | -21.04M | -1.29 |
|
LLY
Lilly Eli Co
|
812.69 | 723.06B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
168.30 | 407.97B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
190.28 | 337.08B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
117.70 | 227.39B | 55.19B | 13.65B | 16.81B | 6.86 |
|
NVO
Novo Nordisk Adr
|
71.70 | 314.28B | 43.59B | 15.04B | 10.74B | 3.3766 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-25 | Initiated | D. Boral Capital | Buy |
| Oct-16-24 | Initiated | Alliance Global Partners | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-16-23 | Initiated | B. Riley Securities | Buy |
| Oct-13-23 | Initiated | B. Riley Securities | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
View All
Scilex Holding Company Stock (SCLX) Latest News
What analysts say about Scilex Holding Company Equity Warrant stockGame-changing returns - PrintWeekIndia
Is Scilex Holding Company Equity Warrant a good long term investmentConsistent double returns - Autocar Professional
Will Scilex Holding Company stock benefit from interest rate changesRapidly growing investment returns - jammulinksnews.com
Scilex Holding Company Stock Analysis and ForecastRapid market gains - Autocar Professional
What drives Scilex Holding Company Equity Warrant stock priceOverwhelming financial success - Autocar Professional
Scilex’s Semnur Amends Merger Agreement with Denali - The Globe and Mail
Oramed Pharm and Scilex Finalize Option Agreement - TipRanks
Scilex Holding amends merger agreement with Denali Capital Acquisition - Investing.com
Scilex Holding amends merger agreement with Denali Capital Acquisition By Investing.com - Investing.com UK
Scilex Holding’s New Stock Purchase Agreement with Tumim - TipRanks
Scilex Holding Company: Merger Agreement Amended, Adds Russell Indexes, Reports Earnings, and Announces FDA Approval - AInvest
What drives Scilex Holding Company stock priceMarket-crushing profits - Autocar Professional
Scilex Holding Company Equity Warrant Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com
What analysts say about Scilex Holding Company stockExtraordinary profit generation - Autocar Professional
Published on: 2025-07-23 00:12:24 - jammulinksnews.com
Is Scilex Holding Company a good long term investmentMarket-crushing stock picks - jammulinksnews.com
Is Scilex Holding Company Equity Warrant stock a growth or value playFree Stock Market Knowledge Sharing - Newser
What institutions are buying Scilex Holding Company Equity Warrant stock nowCapital Safe Smart Trades - Newser
Scilex Holding Company Stock (SCLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Scilex Holding Company Stock (SCLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ji Henry | Executive Chairperson |
Oct 31 '24 |
Buy |
0.94 |
8,888 |
8,351 |
320,161 |
| SHAH JAISIM | See Remarks |
Oct 29 '24 |
Buy |
0.99 |
32,000 |
31,670 |
109,333 |
| Followwill Dorman | Director |
Oct 18 '24 |
Buy |
0.99 |
1,000 |
990 |
2,300 |
| Chun Jay | Director |
Oct 18 '24 |
Buy |
0.95 |
5,000 |
4,750 |
112,500 |
| Wu Yue Alexander | Director |
Oct 17 '24 |
Buy |
0.95 |
20,000 |
18,992 |
25,000 |
| Lemus David | Director |
Oct 17 '24 |
Buy |
0.90 |
2,000 |
1,800 |
2,000 |
| Ji Henry | Executive Chairperson |
Oct 17 '24 |
Buy |
0.97 |
10,000 |
9,710 |
60,070 |
| SHAH JAISIM | See Remarks |
Oct 16 '24 |
Buy |
0.99 |
30,000 |
29,751 |
77,333 |
| Ma Stephen Hoi | Chief Financial Officer |
Oct 16 '24 |
Buy |
0.97 |
6,700 |
6,499 |
22,840 |
0.48%
2.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):